Fundz

First Ascent Biomedical raised $6M in an angel investment led by Vidal Duart Enterprises, Inc. to revolutionize cancer treatment with personalized technology.

PRIVATEJan 13, 2025

Amount Raised

$6 Million

Round Type

Angel

MiamiBiotechnologyHealth CareMedicalTherapeutics

Investors

TechstarsVidal Duart EnterprisesVidal Duart Enterprises, Inc.

Description

First Ascent Biomedical has secured a $6 million investment from Vidal Duart Enterprises, Inc., along with co-investment from Techstars. The funding will be used to enhance operations and establish a state-of-the-art lab in Florida, focusing on personalized cancer treatment technologies.

Quick answer

First Ascent Biomedical raised $6 Million in a Angel round, dated January 13, 2025. Investors: Techstars, Vidal Duart Enterprises and Vidal Duart Enterprises, Inc. First Ascent Biomedical is based in Miami, Florida, United States.

How much did First Ascent Biomedical raise?
First Ascent Biomedical raised $6 Million in a Angel round on January 13, 2025.
Who invested in First Ascent Biomedical?
Techstars, Vidal Duart Enterprises and Vidal Duart Enterprises, Inc. are named as investors in this round.
What does First Ascent Biomedical do?
First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment.
Where is First Ascent Biomedical based and how big is it?
First Ascent Biomedical is based in Miami, Florida, United States. Fundz records about 17 employees.
Who are the decision-makers at First Ascent Biomedical?
Fundz holds 1 contact at First Ascent Biomedical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as First Ascent Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
  • Solid IO raised $839K (Seed) on February 24, 2025.
  • Ceretas raised $1M (Seed) on February 21, 2025.
  • MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.
  • Cerula Care raised $3.7M (Seed) on February 12, 2025.
  • Cerula Care raised $5.5M on February 11, 2025.

Who to call at First Ascent Biomedical, and when

A new round usually means First Ascent Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day First Ascent Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at First Ascent Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at First Ascent Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

First Ascent Biomedical

Location

Miami, Florida, United States

About

First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment. The company focuses on personalized cancer care with their innovative platform that integrates drug testing, DNA/RNA sequencing, and AI-guided tumor weakness mapping. Their technology aims to improve patient survival by moving away from one-size-fits-all approaches and providing tailored treatment strategies. They are committed to making cancer care widely accessible, especially for underserved communities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment First Ascent Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for First Ascent Biomedical's next move

See what Strategic adds

First Ascent Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.